Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Patent
1989-09-13
1991-10-22
Shippen, Michael L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
435106, 43524031, 514565, C07C24100
Patent
active
050597124
ABSTRACT:
Pharmaceutically pure physiologically active N.sup.G -aminoarginine (i.e., the L or D,L form) or pharmaceutically acceptable salt thereof is administered in a nitric oxide synthesis inhibiting amount to a subject in need of such inhibition (e.g. a subject with low blood pressure or needing immunosuppressive effect) or is added to a medium containing isolated organs, intact cells, cell homogenates or tissue homogenates in an amount sufficient to inhibit nitric oxide formation to elucide or control the biosynthesis, metabolism or physiological role of nitric oxide.
N.sup.G -amino-L-arginine is prepared and isolated as a pharmaceutically pure compound by reducing N.sup.G -nitro-L-arginine, converting L-arginine by-product to L-ornithine with arginase and separating N.sup.G -amino-L-arginine from the L-ornithine. N.sup.G -amino-D,L-arginine is prepared in similar fashion starting with N.sup.G -nitro-D,L-arginine.
REFERENCES:
patent: 4282217 (1981-08-01), Baglioni
patent: 4698442 (1987-10-01), Nestor et al.
Palmer, R. M. J. et al., Biochem and Biophysical Research Communications, 153, No. 3, 1251-1256 (6/88).
Steuhr, D. J., et al. The Journal of Immunology, 139, No. 2, 518-525, (1987).
Schmidt, H. H. H. W. et al., European Journal of Pharmacology, 154, 213-216, (1988).
Steuhr, D. J. et al., J. Exp. Med. vol. 169, pp. 1011-1020 (Mar. 1989).
Stuehr, D. J. et al., J. Biochem. and Biophysical Research Communications, vol. 161, No. 2, pp. 420-426 (Jun. 15, 1989).
Turan, A. et al., Acta Chimica Academiae Scientiarum Hungaricae, Tomus 85 (3), pp. 327-332 (1975).
Aisaka, K., et al., Biochemical and Biophysic Research Communications, vol. 160, No. 2, pp. 881-886, 4/28/89.
Iyengar, R. et al. Proc. Natl. Acad. Sci, U.S.A., vol. 84, pp. 6369-6373, 9/87.
Palmer, R. M. J. et al., Nature (London) 333, pp. 664-666, 1988.
Rees, D. D., et al. Proc. Natl. Acad. Sci. U.S.A., vol. 86, pp. 3375-3378, 5/89.
Kilbourn, R. G. et al., Proc. Natl. Acad. Sci. U.S.A., vol. 87, pp. 3629-3632, 5/90.
Sakuma, I. et al., Proc. Natl. Acad. Sci. U.S.A., vol. 85, pp. 8664-8667, 11/88.
Cornell Research Foundation Inc.
Shippen Michael L.
LandOfFree
Isolating aminoarginine and use to block nitric oxide formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolating aminoarginine and use to block nitric oxide formation , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolating aminoarginine and use to block nitric oxide formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-109467